ADS-5102 provided reduction in motor complications in Parkinson's disease patients with levodopa-induced dyskinesia switched from amantadine IR: Subgroup analysis from open-label study (ease LID 2)

被引：3

作者：

Isaacson, S. ^{[1
]}

Pahwa, R. ^{[2
]}

Tanner, C. ^{[3
,4
]}

Fahn, S. ^{[5
]}

Espay, A. ^{[6
]}

Trenkwalder, C. ^{[7
]}

Patni, R. ^{[8
]}

机构：

[1] Parkinsons Dis & Movement Disorders Ctr Boca Rato, Neurol, Boca Raton, FL USA

[2] Univ Kansas, Med Ctr, Neurol, Kansas City, KS 66103 USA

[3] Univ Calif San Francisco, San Francisco, CA 94143 USA

[4] San Francisco VA Med Ctr, Neurol, San Francisco, CA USA

[5] Columbia Univ, Neurol, New York, NY USA

[6] Univ Cincinnati, Neurol, Cincinnati, OH USA

[7] Univ Med Ctr, Neurol, Kassel & Clin Neurosurg, Paracelsus Elena Klin, Gottingen, Germany

[8] Adamas Pharmaceut, Med Affairs, Emeryville, CA USA

来源：

关键词：

D O I：

10.1016/j.jns.2017.08.1008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

980

引用

页码：355 / 355

页数：1